Atlas Trials

Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer

Clinical trial NCT02316340 · COMPLETED

Trial details

NCT number
NCT02316340
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2015-02-11
Primary completion
2018-03-07
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.